Effects on Aerosol Performance of Mixing of Either Budesonide or Beclomethasone Dipropionate With Albuterol and Ipratropium Bromide

References

1. 1.↵
   1. Dolovich MB,
   2. Ahrens RC,
   3. Hess DR,
   4. Anderson P,
   5. Dhand D,
   6. Rau JL,
   7. et al

   . Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335–371.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Barta SK,
   2. Crawford A,
   3. Roberts CM

   . Survey of patients' views of domiciliary nebulizer treatment for chronic lung disease. Respir Med 2002;96(6):375–381.

   OpenUrlCrossRefPubMed
3. 3.
   1. Melani AS,
   2. Sestini P,
   3. Aiolfi S,
   4. Barbato N,
   5. Canessa P,
   6. DeAngelis G,
   7. et al

   ; Associazione Italiana Pneumologi Ospedalieri (AIPO) Educational Group. GENebu Project: home nebulizer use and maintenance in Italy. Eur Respir J 2001;18(5):758–763.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Marcus P,
   2. Oppenheimer EA,
   3. Patel PA,
   4. Katz LM,
   5. Doyle JJ

   . Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcome. Ann Allergy Asthma Immunol 2006;96(5):736–743.

   OpenUrlPubMed
5. 5.↵
   1. Newman SP,
   2. Chan HK

   . In vitro/in vivo comparisons in pulmonary drug delivery. J Aerosol Med Pulm Drug Deliv 2008;21(1):77–84.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Nikander K,
   2. Turpeinen M,
   3. Wollmer P

   . The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med 1999;12(2):47–53.

   OpenUrlPubMedWeb of Science
7. 7.
   1. Smaldone GC,
   2. Cruz-Rivera M,
   3. Nikander K

   . In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 1998;11:113–125.

   OpenUrlCrossRefWeb of Science
8. 8.↵
   1. Berg E,
   2. Picard RJ

   . In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations. Respir Care 2009;54(12):1671–1678.

   OpenUrlPubMed
9. 9.↵
   1. Pujol MS,
   2. Menat C,
   3. Henon T,
   4. Jacquet M,
   5. Woronoff Lemsi MC

   . [Prescriptions of aerosol therapy. A survey of practices at the Besançon University Hospital] Presse Med 2000;29(15):824–828. Article in French.

   OpenUrlPubMed
10. 10.↵
    1. Melani AS,
    2. Pirrelli M,
    3. Sestini P,
    4. DelDonno M,
    5. Bonavia M,
    6. Canessa P,
    7. et al

    ; Associazione Italiana Pneumologi Ospedalieri Educational Group. GENebu Project Equipment and drugs used for home nebulizer therapy in Italy. Monaldi Arch Chest Dis 2002;57(5-6):231–236.

    OpenUrlPubMed
11. 11.↵
    1. McKenzie JE,
    2. Cruz-Rivera M

    . Compatibility of budesonide inhalation suspension for four nebulizing solutions. Ann Pharmacother 2004;38(6):967–972.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.
    1. Kamin W,
    2. Schwabe A,
    3. Krämer I

    . Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Int J Chron Obstruct Pulmon Dis 2007;2(4):599–607.

    OpenUrlPubMed
13. 13.
    1. Bonasia PJ,
    2. McVicar WK,
    3. Williams B,
    4. Ong S

    . Chemical and physical compatibility of levoalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium. Respir Care 2008;53(12):1716–1722.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Akapo S,
    2. Gupta J,
    3. Martinez E,
    4. McCrea C,
    5. Ye L,
    6. Roach M

    . Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Ann Pharmacother 2008;42(10):1416–1424.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Nicolini G,
    2. Cremonesi G,
    3. Melani AS

    . Inhaled corticosteroid therapy with nebulized beclomethasone dipropionate. Pulm Pharmacol Ther 2010;23(3):145–155.

    OpenUrlPubMed
16. 16.↵
    1. Karnes HT,
    2. Shiu G,
    3. Shah VP

    . Validation of bioanalytical methods. Pharm Res 1991;8(4):421–426.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    Comité Européen Normalisé. Respiratory therapy equipment: part 1: nebulizing systems and their components. prEN 13544-1.
18. 18.↵
    1. Dennis JH

    . Standardization issues: in vitro assessment of nebulizer performance. Respir Care 2002;47(12):1445–1448.

    OpenUrlPubMed
19. 19.↵
    1. Kradjan WA,
    2. Lakshminarayan S

    . Efficiency of air compressor driven nebulisers. Chest 1985;87(4):512–516.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Tandon R,
    2. McPeck M,
    3. Smaldone GC

    . Measuring nebulizer output. Aerosol production vs. gravimetric analysis Chest 1997;111(5):1361–1365.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Barry PW,
    2. O'Callaghan C

    . Drug output from nebulizers is dependent on the method of measurement. Eur Respir J 1998;12(2):463–466.

    OpenUrlAbstract
22. 22.↵
    1. Barry PW,
    2. O'Callaghan C

    . An in vitro analysis of the output of budesonide from different nebulisers. J Allergy Clin Immunol 1999;104(6):1168–1173.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. O'Callaghan C

    . Particle size of beclomethasone dipropionate produced by two nebulisers and two spacer devices. Thorax 1990;45(2):109–111.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Vaghi A,
    2. Berg E,
    3. Liljedahl S,
    4. Svensson JO

    . In vitro comparison of nebulised budesonide (Pulmicort Respules) and beclomethasone dipropionate (Clenil per aerosol). Pulm Pharmacol Ther 2005;18(2):151–153.

    OpenUrlPubMed
25. 25.↵
    1. O'Callaghan C,
    2. White JA,
    3. Jackson JM,
    4. Barry PW,
    5. Kantar A

    . Nebulisation of corticosteroids suspensions and solutions with a β₂-agonist. J Pharm Pharmacol 2008;60(5):601–605.

    OpenUrlPubMed
26. 26.↵
    1. Berlinski A,
    2. Waldrep JC

    . Nebulized drug admixtures: effect on aerosol characteristics and albuterol output. J Aerosol Med 2006;19(4):484–490.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Di Berardino L,
    2. Scaglione F

    . Mixing albuterol and corticosteroid is not additive. Allergy 1999;54(9):1012–1013.

    OpenUrlPubMed